Cargando…
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. METHODS: A total of 160, 51 ICC patients from two institutions between May 2012 and July 2022 were retrospectively...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588260/ https://www.ncbi.nlm.nih.gov/pubmed/37858111 http://dx.doi.org/10.1186/s12885-023-11476-z |
_version_ | 1785123544056725504 |
---|---|
author | Xu, Ying Li, Zhuo Zhou, Yanzhao Yang, Yi Ouyang, Jingzhong Li, Lu Huang, Zhen Ye, Feng Ying, Jianming Zhao, Hong Zhou, Jinxue Zhao, Xinming |
author_facet | Xu, Ying Li, Zhuo Zhou, Yanzhao Yang, Yi Ouyang, Jingzhong Li, Lu Huang, Zhen Ye, Feng Ying, Jianming Zhao, Hong Zhou, Jinxue Zhao, Xinming |
author_sort | Xu, Ying |
collection | PubMed |
description | OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. METHODS: A total of 160, 51 ICC patients from two institutions between May 2012 and July 2022 were retrospectively included as training, external validation cohort. Clinical, radiological and pathological variables were evaluated and collected. Univariate and multivariate analysis were applied to select the significant factors related to VER of ICC. The factors selected were combined to perform stratification of overall survival (OS) using the Kaplan-Meier method with the log-rank test. RESULTS: Overall, 39 patients (24.4%) had VER, whereas 121 (75.6%) did not (non-VER group). In the training cohort, the median OS was 40.5 months (95% CIs: 33.2–47.7 months). The VER group showed significantly worse OS than the non-VER group (median OS: 14.8, 95% CI:11.6–18.0 months vs. 53.4, 34.3–72.6 months; p<0.001), and it was confirmed in the validation cohort (median OS: 22.1, 95% CI: 8.8–35.4 months vs. 40.1, 21.2–59.0 months; p = 0.003). According to the univariate analysis, four variables were significantly different between the VER group and non-VER group (TLSs status, p = 0.028; differentiation, p = 0.023; MVI status, p = 0.012; diameter, p = 0.028). According to the multivariate analysis, MVI-positive status was independently associated with a higher probability of VER (odds ratio [OR], 2.5; 95% CIs,1.16–5.18; p = 0.018), whereas intra-tumoral TLSs-positive status was associated with lower odds of VER (OR, 0.43; 95% CIs, 0.19–0.97; p = 0.041). Based on the TLSs and MVI status, patients of ICC were categorized into four groups: TLSs-positive and MVI-negative (TP/MN); TLSs-negative and MVI-negative (TN/MN); TLSs-positive and MVI-positive (TP/MP), TLSs-negative and MVI-positive groups (TN/MP). In the training cohort, the four groups could be correlated with OS significantly (p<0.001), and it was confirmed in the validation cohort (p<0.001). CONCLUSION: Intra-tumoral TLSs and MVI status are independent predictive factors of VER after surgery, based on which immunovascular stratifications are constructed and associated with OS significantly of resectable intrahepatic cholangiocarcinoma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11476-z. |
format | Online Article Text |
id | pubmed-10588260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105882602023-10-21 Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma Xu, Ying Li, Zhuo Zhou, Yanzhao Yang, Yi Ouyang, Jingzhong Li, Lu Huang, Zhen Ye, Feng Ying, Jianming Zhao, Hong Zhou, Jinxue Zhao, Xinming BMC Cancer Research OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. METHODS: A total of 160, 51 ICC patients from two institutions between May 2012 and July 2022 were retrospectively included as training, external validation cohort. Clinical, radiological and pathological variables were evaluated and collected. Univariate and multivariate analysis were applied to select the significant factors related to VER of ICC. The factors selected were combined to perform stratification of overall survival (OS) using the Kaplan-Meier method with the log-rank test. RESULTS: Overall, 39 patients (24.4%) had VER, whereas 121 (75.6%) did not (non-VER group). In the training cohort, the median OS was 40.5 months (95% CIs: 33.2–47.7 months). The VER group showed significantly worse OS than the non-VER group (median OS: 14.8, 95% CI:11.6–18.0 months vs. 53.4, 34.3–72.6 months; p<0.001), and it was confirmed in the validation cohort (median OS: 22.1, 95% CI: 8.8–35.4 months vs. 40.1, 21.2–59.0 months; p = 0.003). According to the univariate analysis, four variables were significantly different between the VER group and non-VER group (TLSs status, p = 0.028; differentiation, p = 0.023; MVI status, p = 0.012; diameter, p = 0.028). According to the multivariate analysis, MVI-positive status was independently associated with a higher probability of VER (odds ratio [OR], 2.5; 95% CIs,1.16–5.18; p = 0.018), whereas intra-tumoral TLSs-positive status was associated with lower odds of VER (OR, 0.43; 95% CIs, 0.19–0.97; p = 0.041). Based on the TLSs and MVI status, patients of ICC were categorized into four groups: TLSs-positive and MVI-negative (TP/MN); TLSs-negative and MVI-negative (TN/MN); TLSs-positive and MVI-positive (TP/MP), TLSs-negative and MVI-positive groups (TN/MP). In the training cohort, the four groups could be correlated with OS significantly (p<0.001), and it was confirmed in the validation cohort (p<0.001). CONCLUSION: Intra-tumoral TLSs and MVI status are independent predictive factors of VER after surgery, based on which immunovascular stratifications are constructed and associated with OS significantly of resectable intrahepatic cholangiocarcinoma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11476-z. BioMed Central 2023-10-19 /pmc/articles/PMC10588260/ /pubmed/37858111 http://dx.doi.org/10.1186/s12885-023-11476-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xu, Ying Li, Zhuo Zhou, Yanzhao Yang, Yi Ouyang, Jingzhong Li, Lu Huang, Zhen Ye, Feng Ying, Jianming Zhao, Hong Zhou, Jinxue Zhao, Xinming Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
title | Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
title_full | Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
title_fullStr | Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
title_full_unstemmed | Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
title_short | Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
title_sort | using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588260/ https://www.ncbi.nlm.nih.gov/pubmed/37858111 http://dx.doi.org/10.1186/s12885-023-11476-z |
work_keys_str_mv | AT xuying usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT lizhuo usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT zhouyanzhao usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT yangyi usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT ouyangjingzhong usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT lilu usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT huangzhen usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT yefeng usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT yingjianming usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT zhaohong usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT zhoujinxue usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma AT zhaoxinming usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma |